101 results
8-K
EX-99.1
BTTX
Better Therapeutics Inc
11 Mar 24
Regulation FD Disclosure
9:01am
of the Company to address the underlying causes of certain diseases and its related potential to improve patient health while lowering healthcare costs … of healthcare providers and payers in PDTs, including AspyreRx, the future financial stability, strength, or success of the Company, and legislative
8-K
EX-99.1
BTTX
Better Therapeutics Inc
4 Mar 24
Regulation FD Disclosure
8:51am
of the first five employees of another healthcare company called Myovant Sciences. I helped the company go public in what became the largest biotech … Therapeutics as CEO, because I think this company has the opportunity to have a massive impact in some of the largest indications in healthcare and in doing so
424B3
BTTX
Better Therapeutics Inc
10 Jan 24
Prospectus supplement
7:01am
diabetes (T2D) into Glooko’s diabetes management platform. This collaboration will enable healthcare providers in the United States who use the Glooko … healthcare provider (HCP) platform in the U.S. as a new treatment option. Additionally, by leveraging Glooko’s ‘precision engagement’ functionality, patients
8-K
EX-99.1
BTTX
Better Therapeutics Inc
8 Jan 24
Better Therapeutics and Glooko Announce Partnership to Accelerate Adoption of AspyreRx to Treat Type 2 Diabetes in the United States
4:42pm
management platform. This collaboration will enable healthcare providers in the United States who use the Glooko platform to identify suitable patients … with diabetes and are utilized in nearly 5,000 clinic locations. AspyreRx will be accessible on the Glooko healthcare provider (HCP) platform in the U.S
424B3
9197x8fjlu
28 Dec 23
Prospectus supplement
9:23pm
8-K
EX-99.1
udn3fa2h 07z5
9 Nov 23
Better Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates
7:03am
424B5
cqqky6
9 Aug 23
Prospectus supplement for primary offering
4:37pm
8-K
EX-99.1
jrynbxl1dxs 6if0yf
9 Aug 23
Better Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates
4:07pm
8-K
EX-99.1
tnqe22s
26 Jul 23
Better Therapeutics Announces $6.7 Million in New Financing at an Average Price of $0.77 per Share
5:11pm
424B5
hy1pcb3q4oua6 fd0
26 Jul 23
Prospectus supplement for primary offering
5:04pm